Genetic Changes Driving Immunosuppressive Microenvironments in Oral Premalignancy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genetic Changes Driving Immunosuppressive Microenvironments in Oral Premalignancy
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-01-27
DOI
10.3389/fimmu.2022.840923
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mutant p53 suppresses innate immune signaling to promote tumorigenesis
- (2021) Monisankar Ghosh et al. CANCER CELL
- Predicting the clinical outcome of oral potentially malignant disorders using transcriptomic-based molecular pathology
- (2021) Hans Prakash Sathasivam et al. BRITISH JOURNAL OF CANCER
- Immune evasion in HPV− head and neck precancer–cancer transition is driven by an aneuploid switch involving chromosome 9p loss
- (2021) William N. William et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epithelial Mutant p53 Promotes Resistance to Anti-PD-1-Mediated Oral Cancer Immunoprevention in Carcinogen-Induced Mouse Models
- (2021) Jin Wang et al. Cancers
- The Role of Dectin-1 Signaling in Altering Tumor Immune Microenvironment in the Context of Aging
- (2021) Natarajan Bhaskaran et al. Frontiers in Oncology
- Local Anti–PD-1 Delivery Prevents Progression of Premalignant Lesions in a 4NQO-Oral Carcinogenesis Mouse Model
- (2021) Yewen Shi et al. Cancer Prevention Research
- Immunohistochemical staining patterns of p53 predict the mutational status of TP53 in oral epithelial dysplasia
- (2021) Keisuke Sawada et al. MODERN PATHOLOGY
- TP53 missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment
- (2021) Martino Maddalena et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cigarette smoke promotes oral leukoplakia via regulating glutamine metabolism and M2 polarization of macrophage
- (2021) Yanan Zhu et al. International Journal of Oral Science
- 9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy
- (2021) Guangchun Han et al. Nature Communications
- PD-1/PD-L1, Treg-related proteins, and tumour-infiltrating lymphocytes are associated with the development of oral squamous cell carcinoma
- (2021) Omar Kujan et al. PATHOLOGY
- Notch1/2/3/4 are prognostic biomarker and correlated with immune infiltrates in gastric cancer
- (2020) Jian Hu et al. Aging-US
- Malignant transformation of oral leukoplakia is associated with macrophage polarization
- (2020) Manuel Weber et al. Journal of Translational Medicine
- The evolutionary history of 2,658 cancers
- (2020) Moritz Gerstung et al. NATURE
- Myeloid derived suppressor cells contribute to the malignant progression of oral squamous cell carcinoma
- (2020) Xin Pang et al. PLoS One
- Cancer-Specific Loss of p53 Leads to a Modulation of Myeloid and T Cell Responses
- (2020) Julianna Blagih et al. Cell Reports
- A PIK3CA transgenic mouse model with chemical carcinogen exposure mimics human oral tongue tumorigenesis
- (2020) Melody T. Tan et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Porphyromonas gingivalis Promotes Oral Squamous Cell Carcinoma Progression in an Immune Microenvironment
- (2020) L. Wen et al. JOURNAL OF DENTAL RESEARCH
- Specific Deletion of p16 with Retention of p19 Enhances the Development of Invasive Oral Squamous Cell Carcinoma
- (2020) Kazuhisa Ishida et al. AMERICAN JOURNAL OF PATHOLOGY
- Prevalence of PD‐L1 expression in head and neck squamous precancerous lesions: a systematic review and meta‐analysis
- (2020) Ilaria Girolami et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- PRMT5 control of cGAS/STING and NLRC5 pathways defines melanoma response to antitumor immunity
- (2020) Hyungsoo Kim et al. Science Translational Medicine
- Targeting of CD40 and PD-L1 Pathways Inhibits Progression of Oral Premalignant Lesions in a Carcinogen-induced Model of Oral Squamous Cell Carcinoma
- (2020) Jose A. Monteiro de Oliveira Novaes et al. Cancer Prevention Research
- Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer
- (2020) Saman Warnakulasuriya et al. ORAL DISEASES
- Tissue Biomarkers for Predicting the Risk of Oral Cancer in Patients Diagnosed with Oral Leukoplakia. A Systematic Review
- (2020) Luis Monteiro et al. ORAL DISEASES
- Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells
- (2020) Clara Gómez-Aleza et al. Nature Communications
- Relationship of infiltrating intraepithelial T lymphocytes in the diagnosis of oral lichen planus versus oral epithelial dysplasia: a pilot study
- (2019) Andres Flores-Hidalgo et al. Oral Surgery Oral Medicine Oral Pathology Oral Radiology
- Advances in immunotherapy delivery from implantable and injectable biomaterials
- (2019) David G. Leach et al. Acta Biomaterialia
- Regulatory T (Treg) cells in cancer: can Treg cells be a new therapeutic target?
- (2019) Yoshihiro Ohue et al. CANCER SCIENCE
- Regulatory T cells and M2-polarized tumour-associated macrophages are associated with the oncogenesis and progression of oral squamous cell carcinoma
- (2019) A. Kouketsu et al. INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes
- (2019) Xiao-Jie Chen et al. PATHOLOGY RESEARCH AND PRACTICE
- Exome sequencing of oral leukoplakia and oral squamous cell carcinoma implicates DNA damage repair gene defects in malignant transformation
- (2019) Camile S. Farah et al. ORAL ONCOLOGY
- Analysis of head and neck carcinoma progression reveals novel and relevant stage-specific changes associated with immortalisation and malignancy
- (2019) Ratna Veeramachaneni et al. Scientific Reports
- Drug-Mimicking Nanofibrous Peptide Hydrogel for Inhibition of Inducible Nitric Oxide Synthase
- (2019) David G. Leach et al. ACS Biomaterials-Science & Engineering
- Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta‐analysis of malignant transformation rate by subtype
- (2019) Oreste Iocca et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Neutrophil-to-lymphocyte ratio in head and neck cancer prognosis: A systematic review and meta-analysis
- (2018) Marco A. Mascarella et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Correction: STING expression and response to treatment with STING ligands in premalignant and malignant disease
- (2018) Jason R. Baird et al. PLoS One
- Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma
- (2018) Yusheng Cheng et al. Cell Death & Disease
- Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246
- (2018) Tomer Cooks et al. Nature Communications
- Oral inflammation promotes oral squamous cell carcinoma invasion
- (2018) Cameron Goertzen et al. Oncotarget
- Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden
- (2018) Carl Morrison et al. Journal for ImmunoTherapy of Cancer
- Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
- (2018) Yannick Simoni et al. NATURE
- Immunological and classical subtypes of oral premalignant lesions
- (2018) Jean-Philippe Foy et al. OncoImmunology
- Role of the cGAS–STING pathway in cancer development and oncotherapeutic approaches
- (2018) Li Teng Khoo et al. EMBO REPORTS
- Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma
- (2017) Si-Rui Ma et al. Molecular Cancer
- Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1
- (2017) Noriaki Tanaka et al. ONCOGENE
- Programmed death ligand 1 (PD-L1) expression and tumor microenvironment: Implications for patients with oral precancerous lesions
- (2017) Takahiro Yagyuu et al. ORAL ONCOLOGY
- Mutant p53 shapes the enhancer landscape of cancer cells in response to chronic immune signaling
- (2017) Homa Rahnamoun et al. Nature Communications
- Blockade of PD-1 effectively inhibits in vivo malignant transformation of oral mucosa
- (2017) Yichen Chen et al. OncoImmunology
- Expression of inducible nitric oxide synthase (iNOS) in oral precancer and oral squamous cell carcinoma: An immunohistochemical study
- (2017) Soma Susan Varghese et al. Cancer Biomarkers
- The blockage of Notch signalling promoted the generation of polymorphonuclear myeloid-derived suppressor cells with lower immunosuppression
- (2016) Shu-Hong Wang et al. EUROPEAN JOURNAL OF CANCER
- Inflammation-induced myeloid-derived suppressor cells associated with squamous cell carcinoma of the head and neck
- (2016) Wen-Cheng Chen et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- TP53Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response
- (2016) Ge Zhou et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Cdkn2asuppresses metastasis in squamous cell carcinomas induced by the gain-of-function mutantp53R172H
- (2016) Zhongyou Li et al. JOURNAL OF PATHOLOGY
- Immunosuppression Induced by Chronic Inflammation and the Progression to Oral Squamous Cell Carcinoma
- (2016) Yujuan Sun et al. MEDIATORS OF INFLAMMATION
- Tumor-associated macrophages in oral premalignant lesions coexpress CD163 and STAT1 in a Th1-dominated microenvironment
- (2015) Kazumasa Mori et al. BMC CANCER
- Notch1 Activation or Loss Promotes HPV-Induced Oral Tumorigenesis
- (2015) Rong Zhong et al. CANCER RESEARCH
- Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulateVEGFR2in breast cancer cells
- (2015) Neil T. Pfister et al. GENES & DEVELOPMENT
- Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth
- (2015) Jiajun Zhu et al. NATURE
- Myeloid cell-derived inducible nitric oxide synthase suppresses M1 macrophage polarization
- (2015) Geming Lu et al. Nature Communications
- Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
- (2014) Patricia A.J. Muller et al. CANCER CELL
- iNOS Expression in CD4+ T Cells Limits Treg Induction by Repressing TGF 1: Combined iNOS Inhibition and Treg Depletion Unmask Endogenous Antitumor Immunity
- (2014) P. Jayaraman et al. CLINICAL CANCER RESEARCH
- Expression of CD163, interleukin-10, and interferon-gamma in oral squamous cell carcinoma: mutual relationships and prognostic implications
- (2014) Shan Wang et al. EUROPEAN JOURNAL OF ORAL SCIENCES
- STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
- (2014) Seng-Ryong Woo et al. IMMUNITY
- Mutant p53 Reprograms TNF Signaling in Cancer Cells through Interaction with the Tumor Suppressor DAB2IP
- (2014) Giulio Di Minin et al. MOLECULAR CELL
- Copy Number Loss of the Interferon Gene Cluster in Melanomas Is Linked to Reduced T Cell Infiltrate and Poor Patient Prognosis
- (2014) Peter S. Linsley et al. PLoS One
- Mutant p53 Prolongs NF-κB Activation and Promotes Chronic Inflammation and Inflammation-Associated Colorectal Cancer
- (2013) Tomer Cooks et al. CANCER CELL
- Effects of Notch Signaling on Regulation of Myeloid Cell Differentiation in Cancer
- (2013) P. Cheng et al. CANCER RESEARCH
- Molecular Pathways: Inflammation-Associated Nitric-Oxide Production as a Cancer-Supporting Redox Mechanism and a Potential Therapeutic Target
- (2013) E. A. Grimm et al. CLINICAL CANCER RESEARCH
- Increased frequency of CD4+ CD25+ FOXP3+ cells correlates with the progression of 4-nitroquinoline1-oxide-induced rat tongue carcinogenesis
- (2013) Jianjiang Zhao et al. Clinical Oral Investigations
- T cell–derived inducible nitric oxide synthase switches off TH17 cell differentiation
- (2013) Jianjun Yang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Integrative Genomic Characterization of Oral Squamous Cell Carcinoma Identifies Frequent Somatic Drivers
- (2013) C. R. Pickering et al. Cancer Discovery
- Mutant p53: one name, many proteins
- (2012) W. A. Freed-Pastor et al. GENES & DEVELOPMENT
- Evaluation of MAGE-A expression and grade of dysplasia for predicting malignant progression of oral leukoplakia
- (2012) JUTTA RIES et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Tumor-Expressed Inducible Nitric Oxide Synthase Controls Induction of Functional Myeloid-Derived Suppressor Cells through Modulation of Vascular Endothelial Growth Factor Release
- (2012) P. Jayaraman et al. JOURNAL OF IMMUNOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Type I interferon is selectively required by dendritic cells for immune rejection of tumors
- (2011) Mark S. Diamond et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1
- (2011) N. Agrawal et al. SCIENCE
- Infiltration of M2 Tumor-Associated Macrophages in Oral Squamous Cell Carcinoma Correlates with Tumor Malignancy
- (2011) Kazumasa Mori et al. Cancers
- Notch Signaling Determines the M1 versus M2 Polarization of Macrophages in Antitumor Immune Responses
- (2010) Yao-Chun Wang et al. CANCER RESEARCH
- Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells
- (2010) S. Nagaraj et al. JOURNAL OF IMMUNOLOGY
- Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients
- (2009) H. M. Ögmundsdóttir et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Mutant p53 Gain-of-Function in Cancer
- (2009) M. Oren et al. Cold Spring Harbor Perspectives in Biology
- Overexpression of human β-defensin-3 in oral dysplasia: Potential role in macrophage trafficking
- (2008) Hameem I. Kawsar et al. ORAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now